Literature DB >> 4659044

In vivo methods for the assessment of antibody-mediated tumor immunity.

H J Winn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4659044

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  4 in total

1.  Treatment of lung cancer using clinically relevant oral doses of the cyclooxygenase-2 inhibitor rofecoxib: potential value as adjuvant therapy after surgery.

Authors:  Tomoyuki Tanaka; Peter A Delong; Kunjlata Amin; Adam Henry; Robert Kruklitis; Veena Kapoor; Larry R Kaiser; Steven M Albelda
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

2.  The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells.

Authors:  Jon G Quatromoni; Eiji Suzuki; Olugbenga Okusanya; Brendan F Judy; Pratik Bhojnagarwala; Ollin Venegas; Evgeniy Eruslanov; Jarrod D Predina; Steven M Albelda; Sunil Singhal
Journal:  BMC Immunol       Date:  2013-07-17       Impact factor: 3.615

3.  Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness.

Authors:  Jarrod D Predina; Veena Kapoor; Brendan F Judy; Guanjun Cheng; Zvi Gregory Fridlender; Steven M Albelda; Sunil Singhal
Journal:  J Hematol Oncol       Date:  2012-06-28       Impact factor: 17.388

4.  The vascular bed as the primary target in the destruction of skin grafts by antiserum. II. Loss of sensitivity to antiserum in long-term xenografts of skin.

Authors:  S V Jooste; R B Colvin; H J Winn
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.